Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Oxawel
Oxawel (Oxaliplatin Injection 100 mg) is a chemotherapeutic agent used in the treatment of advanced colorectal cancer and other solid tumors. It is part of the platinum-based chemotherapy class and is commonly combined with other medications such as fluorouracil (5-FU) and leucovorin to enhance therapeutic efficacy. By disrupting DNA synthesis within cancer cells, Oxawel prevents tumor growth and spread, providing a critical treatment option in the management of cancer.
Uses of Oxawel
Oxawel is primarily used for:
Adjuvant Treatment of Colorectal Cancer
Advanced Colorectal Cancer (Metastatic Stage)
Neoadjuvant Chemotherapy for Colorectal Cancer
Other Solid Tumors (e.g., Ovarian, Gastric, Pancreatic Cancer)
Benefits of Oxawel
Effective in Treating Advanced Colorectal Cancer
Part of Combination Chemotherapy Regimen for Maximum Effectiveness
Targets Tumor DNA to Prevent Growth and Spread
Improves Survival Rates in Colorectal Cancer Patients
Well-Tolerated in Many Patients with Managed Side Effects
Mechanism of Action of Oxawel
Oxawel contains Oxaliplatin, a platinum-based compound that works by forming cross-links with DNA, which inhibit DNA replication and transcription. This process prevents the division of cancer cells, leading to cell death. By interfering with the cancer cell’s genetic material, Oxawel slows or stops the progression of tumors, particularly in colorectal cancer. The drug is more effective when used in combination with fluorouracil (5-FU), which works by further blocking cancer cell growth.